Kanvas Bio
About Kanvas Bio
Kanvas Bio is a biotechnology company focused on mapping the microbiome to accelerate therapeutic discovery. Their full-stack platform provides spatial biology capabilities to visualize host-microbiome interactions and uncover novel therapeutic opportunities. Their HiPR-Fish and imaging technologies aim to illuminate microbiome dynamics in health and disease, enabling more precise interventions. The company operates in the biological research space with a global orientation, highlighted by imaging-driven microbiome research and drug development initiatives.
Recent News
The Gates Foundation Is Funding A Startup’s Plan To Fight Malnutrition With Bacteria
Follow the Money: AI Drug Design Engine, Treating Multiple Myeloma, Quantum Healthcare Platform
Kanvas Biosciences Receives New Funding to Develop First-In-Category Microbiome Therapeutic for Improving Maternal, Newborn and Child Health
Funding Roundup: Kanvas Biosciences, LTZ Therapeutics Draw Investor Interest for Next-Generation Cancer Immunotherapies